Clinical Trials Browser

Bulbo-Spinal Atrophy, X-Linked × darolutamide × 90 days × Clear all

NCT07190300 2026-06-03

TulmiSTAR-02

Phase 1/2 Recruiting

Bulbo-Spinal Atrophy, X-Linked

NCT05694819 2026-04-08

Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)

Phase 2 Completed

Salivary Gland Neoplasms, Bulbo-Spinal Atrophy, X-Linked